Plus Therapeutics | CYTX - Despesas Operacionais

Preço das Ações
4.80
Mudança Diária
0.88 22.45%
Mensal
-37.60%
Anual
-74.40%
Q2 Previsão
4.67




Despesas Operacionais Alterar Data
Baxter International USD 3.19B 554.4M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Dr.Reddys Laboratories INR 73.6B 1.79B 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
Northwest Biotherapeutics USD -108.65M 8.26M 2025-09
Plus Therapeutics USD 7.11M 1.23M 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Sun Pharmaceuticals INR 111.11B 6.97B 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12